141 related articles for article (PubMed ID: 38070223)
1. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting.
Bhat AA; Afzal O; Afzal M; Gupta G; Thapa R; Ali H; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Samuel VP; Gubbiyappa SK; Subramaniyan V
Pathol Res Pract; 2024 Jan; 253():154991. PubMed ID: 38070223
[TBL] [Abstract][Full Text] [Related]
2. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
[TBL] [Abstract][Full Text] [Related]
3. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
4. From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression.
Thapa R; Afzal O; Afzal M; Gupta G; Bhat AA; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Arora P; Singh SK; Dua K
Pathol Res Pract; 2024 Jan; 253():154959. PubMed ID: 38029713
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 signaling pathway and clinical applications in overcome on cancers metastasis.
Mazarei M; Shahabi Rabori V; Ghasemi N; Salehi M; Rayatpisheh N; Jahangiri N; Saberiyan M
Clin Exp Med; 2023 Dec; 23(8):4457-4472. PubMed ID: 37695391
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
9.
Tie W; Ge F
DNA Cell Biol; 2021 Nov; 40(11):1407-1417. PubMed ID: 34610246
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
Yue X; Wu WY; Dong M; Guo M
Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
[TBL] [Abstract][Full Text] [Related]
12. PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities.
Hakami MA; Hazazi A; Khan FR; Abdulaziz O; Alshaghdali K; Abalkhail A; Nassar SA; Omar BIA; Almarshadi F; Gupta G; Binshaya AS
Pathol Res Pract; 2024 Jan; 253():155019. PubMed ID: 38091883
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.
Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q
Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA MALAT1 Promotes Laryngocarcinoma Development by Targeting miR-708-5p/BRD4 Axis to Regulate YAP1-Mediated Epithelial-Mesenchymal Transition.
Wu X; Tan Y; Tang X
Biomed Res Int; 2022; 2022():8093949. PubMed ID: 35601153
[TBL] [Abstract][Full Text] [Related]
15. Functions and regulatory mechanisms of metastasis-associated lung adenocarcinoma transcript 1.
Lei L; Chen J; Huang J; Lu J; Pei S; Ding S; Kang L; Xiao R; Zeng Q
J Cell Physiol; 2018 Jan; 234(1):134-151. PubMed ID: 30132842
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer.
Xu W; Ding M; Wang B; Cai Y; Guo C; Yuan C
Curr Med Chem; 2021; 28(42):8800-8809. PubMed ID: 34036905
[TBL] [Abstract][Full Text] [Related]
17. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer.
Almalki WH
Pathol Res Pract; 2023 Nov; 251():154852. PubMed ID: 37837857
[TBL] [Abstract][Full Text] [Related]
18. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
19. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
[TBL] [Abstract][Full Text] [Related]
20. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
Sun Z; Ou C; Liu J; Chen C; Zhou Q; Yang S; Li G; Wang G; Song J; Li Z; Zhang Z; Yuan W; Li X
Oncogene; 2019 Apr; 38(14):2627-2644. PubMed ID: 30531836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
